Sun Pharma Advanced Research Company Limited
SPARC
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 202630
Quarter ₹ crore YoY Sept 2024 13 -39.3% Dec 2024 15 +7.6% Mar 2025 27 +64.2% Jun 2025 10 -42.7% Sept 2025 8 -38.9% Dec 2025 8 -43.3% Mar 2026 1,853 +6715.8% Jun 2026 40 +314.1% Sept 2026 30 +282.1% - ₹ crore
Sept 202624
Quarter ₹ crore Sept 2024 0.04 Dec 2024 0.19 Mar 2025 0 Jun 2025 9 Sept 2025 0.01 Dec 2025 0 Mar 2026 2 Jun 2026 24 Sept 2026 24 - ₹ crore
Sept 202654
Quarter ₹ crore Sept 2024 13 Dec 2024 15 Mar 2025 27 Jun 2025 19 Sept 2025 8 Dec 2025 8 Mar 2026 1,855 Jun 2026 64 Sept 2026 54 - Cost structure
- ₹ crore
Sept 202624
Quarter ₹ crore Sept 2024 29 Dec 2024 26 Mar 2025 25 Jun 2025 28 Sept 2025 26 Dec 2025 27 Mar 2026 21 Jun 2026 24 Sept 2026 24 - ₹ crore
Sept 202678
Quarter ₹ crore Sept 2024 121 Dec 2024 95 Mar 2025 88 Jun 2025 71 Sept 2025 84 Dec 2025 77 Mar 2026 94 Jun 2026 85 Sept 2026 78 - Exceptional items and tax
- ₹ crore
Sept 2026-25
Quarter ₹ crore Sept 2024 -108 Dec 2024 -80 Mar 2025 -61 Jun 2025 -52 Sept 2025 -76 Dec 2025 -81 Mar 2026 1,761 Jun 2026 -21 Sept 2026 -25 - ₹ crore
Sept 20260
Quarter ₹ crore Sept 2024 0 Dec 2024 0 Mar 2025 0 Jun 2025 0 Sept 2025 0 Dec 2025 0 Mar 2026 0 Jun 2026 0 Sept 2026 0 - Profit
- ₹ crore
Sept 2026-25
Quarter ₹ crore YoY Sept 2024 -108 -24.6%* Dec 2024 -80 +20.0%* Mar 2025 -61 +42.8%* Jun 2025 -52 +46.3%* Sept 2025 -76 +29.5%* Dec 2025 -81 -1.1%* Mar 2026 1,761 +2987.3%* Jun 2026 -21 +59.7%* Sept 2026 -25 +67.6%* - Per share
- ₹ per share
Sept 2026-0.76
Quarter ₹ per share Sept 2024 -3.32 Dec 2024 -2.46 Mar 2025 -1.88 Jun 2025 -1.60 Sept 2025 -2.34 Dec 2025 -2.48 Mar 2026 54.26 Jun 2026 -0.65 Sept 2026 -0.76 - Leverage
Debt to equity
timesSept 20260.00x
Quarter times Sept 2024 — Dec 2024 — Mar 2025 0.00x Jun 2025 — Sept 2025 0.00x Dec 2025 — Mar 2026 0.00x Jun 2026 0.00x Sept 2026 0.00x
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 13 | 15 | 27 | 10 | 8 | 8 | 1,853 | 40 | 30 | |
| Revenue YoY | -39.3% | +7.6% | +64.2% | -42.7% | -38.9% | -43.3% | +6715.8% | +314.1% | +282.1% |
| 0.04 | 0.19 | 0 | 9 | 0.01 | 0 | 2 | 24 | 24 | |
| 13 | 15 | 27 | 19 | 8 | 8 | 1,855 | 64 | 54 | |
| Cost structure | |||||||||
| 29 | 26 | 25 | 28 | 26 | 27 | 21 | 24 | 24 | |
| 121 | 95 | 88 | 71 | 84 | 77 | 94 | 85 | 78 | |
| Exceptional items and tax | |||||||||
| -108 | -80 | -61 | -52 | -76 | -81 | 1,761 | -21 | -25 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit | |||||||||
| -108 | -80 | -61 | -52 | -76 | -81 | 1,761 | -21 | -25 | |
| Net profit YoY | -24.6%* | +20.0%* | +42.8%* | +46.3%* | +29.5%* | -1.1%* | +2987.3%* | +59.7%* | +67.6%* |
| Per share | |||||||||
| -3.32 | -2.46 | -1.88 | -1.60 | -2.34 | -2.48 | 54.26 | -0.65 | -0.76 | |
| Leverage | |||||||||
| Debt to equity | — | — | 0.00x | — | 0.00x | — | 0.00x | 0.00x | 0.00x |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.